Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABIGATRAN ETEXILATE Cause Pyrexia? 190 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Pyrexia have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.5% of all adverse event reports for DABIGATRAN ETEXILATE.

190
Reports of Pyrexia with DABIGATRAN ETEXILATE
0.5%
of all DABIGATRAN ETEXILATE reports
38
Deaths
150
Hospitalizations

How Dangerous Is Pyrexia From DABIGATRAN ETEXILATE?

Of the 190 reports, 38 (20.0%) resulted in death, 150 (78.9%) required hospitalization, and 17 (8.9%) were considered life-threatening.

Is Pyrexia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 190 reports have been filed with the FAERS database.

What Other Side Effects Does DABIGATRAN ETEXILATE Cause?

Gastrointestinal haemorrhage (4,081) Cerebrovascular accident (2,175) Fall (1,786) Ischaemic stroke (1,581) Anaemia (1,412) Haemorrhage (1,324) Death (1,025) Rectal haemorrhage (964) Cerebral haemorrhage (946) Upper gastrointestinal haemorrhage (861)

What Other Drugs Cause Pyrexia?

ADALIMUMAB (12,160) METHOTREXATE (10,158) RITUXIMAB (10,061) PREDNISONE (8,141) ETANERCEPT (7,626) INFLIXIMAB (6,560) ACETAMINOPHEN (6,414) CYCLOPHOSPHAMIDE (6,126) TOCILIZUMAB (5,529) LENALIDOMIDE (5,496)

Which DABIGATRAN ETEXILATE Alternatives Have Lower Pyrexia Risk?

DABIGATRAN ETEXILATE vs DABRAFENIB DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB DABIGATRAN ETEXILATE vs DACARBAZINE DABIGATRAN ETEXILATE vs DACLATASVIR DABIGATRAN ETEXILATE vs DACLIZUMAB

Related Pages

DABIGATRAN ETEXILATE Full Profile All Pyrexia Reports All Drugs Causing Pyrexia DABIGATRAN ETEXILATE Demographics